首页> 外文期刊>Chemistry: A European journal >Magnetic electrochemiluminescent Fe3O4/CdSe-CdS nanoparticle/polyelectrolyte nanocomposite for highly efficient immunosensing of a cancer biomarker.
【24h】

Magnetic electrochemiluminescent Fe3O4/CdSe-CdS nanoparticle/polyelectrolyte nanocomposite for highly efficient immunosensing of a cancer biomarker.

机译:磁性电化学发光Fe3O4 / CdSe-CdS纳米颗粒/聚电解质纳米复合材料,用于癌症生物标记物的高效免疫感应。

获取原文
获取原文并翻译 | 示例
           

摘要

Magnetic electrochemiluminescent Fe(3)O(4)/CdSe-CdS nanoparticle/polyelectrolyte nanostructures have been synthesized and used to fabricate an electrochemiluminescence (ECL) immunosensor for the detection of carcinoembryonic antigen (CEA). CEA is a protein used as a biomarker for several cancers; particularly, to monitor response to treatment in colon and rectal cancer patients. The nanocomposites can be easily separated and firmly attached to an electrode owing to their excellent magnetic properties. This represents a promising advantage for bioassay applications. More importantly, the nanostructures exhibit intense and stable ECL emissions in neutral solution, which makes them ideal for ECL immunosensing. The 3-aminopropyltriethoxysilane (APS) polyelectrolyte shell on the nanostructure surface not only enhances the intensity and stability of the ECL signal, but also acts as a crosslinker for immunosensor fabrication. A CEA antibody immobilized onto a nanocomposite/APS/electrode with gold nanoparticles comprises the ECL immunosensor. The principle of ECL detection for CEA is based on a change in steric hindrance after immunoreaction, which leads to a decrease in ECL intensity. A wide detection range (0.064pg ml(-1)-10ng ml(-1)) and low detection limit (0.032pg ml(-1)) are achieved. The immunosensor is highly sensitive and selective, and exhibits excellent stability and good reproducibility. It thus has great potential for clinical protein detection. In particular, this approach uses a novel class of bifunctional nanocomposites that display both intense ECL and excellent magnetism, which renders them suitable for a large range of bioassay applications.
机译:磁性电化学发光Fe(3)O(4)/ CdSe-CdS纳米颗粒/聚电解质纳米结构已被合成,并用于制造用于检测癌胚抗原(CEA)的电致发光(ECL)免疫传感器。 CEA是一种蛋白质,可用于多种癌症的生物标记。特别是监测结肠癌和直肠癌患者对治疗的反应。纳米复合材料具有出色的磁性,因此可以轻松分离并牢固地附着在电极上。这代表了生物测定应用的有前途的优势。更重要的是,纳米结构在中性溶液中表现出强烈且稳定的ECL发射,这使其成为ECL免疫传感的理想选择。纳米结构表面上的3-氨丙基三乙氧基硅烷(APS)聚电解质壳不仅增强了ECL信号的强度和稳定性,而且还充当免疫传感器制造的交联剂。用金纳米颗粒固定在纳米复合材料/ APS /电极上的CEA抗体包含ECL免疫传感器。 CEA的ECL检测原理基于免疫反应后的空间位阻变化,从而导致ECL强度降低。实现了较宽的检测范围(0.064pg ml(-1)-10ng ml(-1))和较低的检测限(0.032pg ml(-1))。该免疫传感器是高度敏感和选择性的,并且表现出优异的稳定性和良好的再现性。因此,它具有临床蛋白质检测的巨大潜力。特别地,该方法使用一类新型的双功能纳米复合材料,该复合材料既显示出强烈的ECL,又具有出色的磁性,这使其适用于多种生物测定应用。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号